| |
| Device | Ventana PD-L1 (SP142) Assay |
| Generic Name | Immunohistochemistry assay, antibody, programmed death-ligand 1 |
| Applicant | Ventana Medical Systems, Inc. 1910 E. Innovation Park Dr. Tucson, AZ 85755 |
| PMA Number | P160002 |
| Supplement Number | S002 |
| Date Received | 03/16/2017 |
| Decision Date | 06/06/2017 |
| Product Code |
PLS |
| Advisory Committee |
Pathology |
| Clinical Trials | NCT02031458
|
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for updated product labeling with additional non-clinical data. |